Their high potency and specific activity in blocking MCFA/GPR84-mediated myeloid cell recruitment supports their further exploration as novel anti-inflammatory and anti-fibrotic agents in NASH. Here, GPR84 is linked to metabolic dysfunction-associated steatohepatitis.